Adjuvant therapy in patients with operable breast carcinoma
Cleton, F.J.; Engelsman, E.; Nooy, M.
Nederlands Tijdschrift Voor Geneeskunde 130(16): 719-721
1986
ISSN/ISBN: 0028-2162 PMID: 3713876 Document Number: 271347
Document emailed within 1 workday
Related Documents
Hudis, C.A.; Norton, L. 1996: Adjuvant drug therapy for operable breast cancer Seminars in Oncology 23(4): 475-493Hooning, M.J.; van Dongen, J.A.; Went, G. 1991: Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation Netherlands Journal of Surgery 43(4): 102-104
O'Brien, P.H. 1976: Adjuvant treatment in operable breast cancer Journal of the South Carolina Medical Association 72(5): 173-174
Rossi, A.; Valagussa, P.; Bonadonna, G. 1977: Surgery and adjuvant chemotherapy in the treatment of operable breast cancer Progress in Clinical and Biological Research 12: 391-404
Rahko, E.; Jukkola, A.; Melkko, J.; Paavo, P.ääk.ö; Bloigu, R.; Talvensaari-Mattila, A.; Turpeenniemi-Hujanen, T. 2004: Matrix metalloproteinase-9 (MMP-9) immunoreactive protein has modest prognostic value in locally advanced breast carcinoma patients treated with an adjuvant antiestrogen therapy Anticancer Research 24(6): 4247-4253
Senn, H.J. 1985: Have therapeutic measures improved the prognosis of operable breast cancer? Adjuvant chemotherapy Verhandlungen der Deutschen Gesellschaft für Innere Medizin 91: 421-428
Schneider, G. 1993: Adjuvant hormone therapy in breast carcinoma Deutsche Medizinische Wochenschrift 118(25): 961-962
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Bartelink, H.; van Dongen, J.A.; van Dam, F.S.; van de Vijver, M. 1983: Breast sparing treatment in operable breast carcinoma; initial assessment of the results Nederlands Tijdschrift Voor Geneeskunde 127(49): 2223-2228
Fey, M.F.; Castiglione-Gertsch, M. 1996: Questions and answers on adjuvant systemic therapy in breast carcinoma Therapeutische Umschau. Revue Therapeutique 53(11): 839-846
Margolis, D.S.; McMillen, M.A.; Hashmi, H.; Wasson, D.W.; MacArthur, J.D. 1992: Aggressive axillary evaluation and adjuvant therapy for nonpalpable carcinoma of the breast Surgery Gynecology and Obstetrics 174(2): 109-113
Fazio, M.; Calabrese, F.; Giacomasso, S.; Mastromatteo, V.; Negri, L. 1988: Adjuvant therapy in breast carcinoma. a specific immunologic preliminary contribution Minerva Chirurgica 43(18 Suppl): 59-62
Senn, H.J. 1987: Current status of adjuvant chemo- and hormone therapy in resectable breast carcinoma Schweizerische Rundschau für Medizin Praxis 76(43): 1193-1199
Goldhirsch, A.; Neuenschwander, H.; Castiglione, M.; Senn, H.J.; Cavalli, F. 1990: Adjuvant systemic therapy in breast carcinoma in the 1990s: status of things and open questions Schweizerische Medizinische Wochenschrift 120(47): 1771-1783
Haagensen, C.D. 1974: The choice of treatment for operable carcinoma of the breast Surgery 76(5): 685-714
Bardi, M.; Arnoldi, E.; Pizzocchero, G.; Pezzica, E.; Mattioni, D.; Perotti, M. 1994: Endometrioid carcinoma in pelvic endometriosis in a postmenopausal woman with tamoxifen adjuvant therapy for breast cancer. A case report European Journal of Gynaecological Oncology 15(5): 393-395
Semiglazov, V.F.; Bavli, I.L.; Moiseenko, V.M. 1986: Adjuvant therapy of breast cancer patients Voprosy Onkologii 32(11): 59-63
Cheix, F.; Biron, A.; Bailly, C.; Mayer, M.; Pommatau, E.; Saez, S. 1980: Operable carcinoma of the breast. Prognostic value of estradiol receptors. Preliminary report La Nouvelle Presse Medicale 9(13): 933-935
Mano, M.P.; Barengo, R.; Sinistrero, G.; Giurgola, L.; Sismondi, P. 1985: Bone marrow toxicity of chemotherapy combinations in operable carcinoma of the breast Minerva Ginecologica 37(6): 335-338
Semiglazov, V.F.; Maximov, S.Y.; Bulgatova, Y., A.; Meshkova, I.Y.; Chepik, O.F.; Berstein, L.M. 2003: Risk of hyperplasia and endometrial carcinoma in breast cancer patients receiving adjuvant tamoxifen Voprosy Onkologii (Stsburg). 49(2): 198-204